WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China's Beautiful Biotech Chaos vs West's Eleg... (12/30/2025)

China Leads Globally in mRNA-Based Therapeutic... (12/27/2025)

China Biotech Raises $362 Million in 18 Financ... (12/27/2025)

NSCEB: US Faces Urgent Challenge to Stay Ahead... (12/23/2025)

China Biopharma Licensing Slows in Value as Ov... (12/22/2025)

U.S. Biosecurity Provisions Could Reshape Chin... (12/19/2025)

Understanding China's Pharmaceutical Patent Li... (12/17/2025)

Understanding China's Pharmaceuticals Patent L... (12/17/2025)

China's New Drug Commercial Insurance Scheme O... (12/17/2025)

Innovative Drugs: The New Battleground in US-C... (12/11/2025)

Chinese Biopharma Sector Posts 22 Financings ... (12/11/2025)

China Tightens Oversight as Domestic Innovator... (12/11/2025)

(1/1/2026) China's Supreme Court Upholds Semaglutid... (1/1/2026) (1/1/2026) CDE Issues Technical Guidelines for Clin... (1/1/2026) CDE Issues Technical Guidelines for Clin... (1/1/2026) CDE Releases Technical Guidelines for Ta... (1/1/2026) CDE Issues Technical Guidelines for Pan-... (1/1/2026) NMPA Publishes 100th Batch of Reference ... (1/1/2026) China's NMPA Issues Updated Bevacizumab ... (1/1/2026) Transcenta and EirGenix Partner to Expan... (1/1/2026) Youcare Files for Hong Kong IPO to Expan... (1/1/2026) Zelgen and AbbVie Strike Global Licensin... (1/1/2026) Akeso's Pempulimab Wins New Approval in ... (1/1/2026) J&J's Subcutaneous Amivantamab Regimen f... (1/1/2026) Kousai Secures Strategic Financing to Ad... (1/1/2026) Moucellion Raises Pre-A Financing to Adv... (1/1/2026) InSilico Debuts on HKEX in Hong Kong's L... (1/1/2026) Suzhou Launches China's First Nuclear Me... (12/30/2025)

China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i...

InSilico Debuts on HKEX in Hong Kong's Largest Biotech ... Moucellion Raises Pre-A Financing to Advance iPSC Thera... Kousai Secures Strategic Financing to Advance Dendritic... Zelgen and AbbVie Strike Global Licensing Deal for Tris... Youcare Files for Hong Kong IPO to Expand Innovative Dr...

China's NMPA Issues Updated Bevacizumab Labeling Requir... NMPA Publishes 100th Batch of Reference Formulations fo... CDE Issues Technical Guidelines for Pan-Cancer Drug Cli... CDE Releases Technical Guidelines for Targeted Biologic... CDE Issues Technical Guidelines for Clinical Trials of ...

NHSA Unveils Three-Year Plan to Accelerate BMI Fund Cle... China Pushes Private Insurance to Cover High-Cost Innov... China Releases Updated NRDL and First Commercial Insura... China's Healthcare Costs Shift to Individuals as Govern... China Expands Grassroots Healthcare Access with More Do...

China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ...

Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ...

J&J's Subcutaneous Amivantamab Regimen for EGFR-Mutant ... Akeso's Pempulimab Wins New Approval in China Innovent Submits Clinical Trial Application for Novel B... Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecifi... China Approves AstraZeneca and Ionis' Wainua for ATTRv-...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves China Moves to Prosecute Former Traditional Medicine Re... Recent Executive Moves Former CFDA Boss Bi Jingquan Expelled From Party, Faces... Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...